Bezerra Frank Silva, Lanzetti Manuella, Nesi Renata Tiscoski, Nagato Akinori Cardozo, Silva Cyntia Pecli E, Kennedy-Feitosa Emanuel, Melo Adriana Correa, Cattani-Cavalieri Isabella, Porto Luís Cristóvão, Valenca Samuel Santos
Department of Biological Sciences, Federal University of Ouro Preto, Ouro Preto 35400-000, Brazil.
Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
Antioxidants (Basel). 2023 Feb 21;12(3):548. doi: 10.3390/antiox12030548.
Acute and chronic lung injuries are among the leading causes of mortality worldwide. Lung injury can affect several components of the respiratory system, including the airways, parenchyma, and pulmonary vasculature. Although acute and chronic lung injuries represent an enormous economic and clinical burden, currently available therapies primarily focus on alleviating disease symptoms rather than reversing and/or preventing lung pathology. Moreover, some supportive interventions, such as oxygen and mechanical ventilation, can lead to (further) deterioration of lung function and even the development of permanent injuries. Lastly, sepsis, which can originate extrapulmonary or in the respiratory system itself, contributes to many cases of lung-associated deaths. Considering these challenges, we aim to summarize molecular and cellular mechanisms, with a particular focus on airway inflammation and oxidative stress that lead to the characteristic pathophysiology of acute and chronic lung injuries. In addition, we will highlight the limitations of current therapeutic strategies and explore new antioxidant-based drug options that could potentially be effective in managing acute and chronic lung injuries.
急性和慢性肺损伤是全球范围内主要的死亡原因之一。肺损伤可影响呼吸系统的多个组成部分,包括气道、实质和肺血管。尽管急性和慢性肺损伤带来了巨大的经济和临床负担,但目前可用的治疗方法主要集中在缓解疾病症状,而非逆转和/或预防肺部病变。此外,一些支持性干预措施,如吸氧和机械通气,可能导致肺功能(进一步)恶化,甚至造成永久性损伤。最后,可起源于肺外或呼吸系统本身的脓毒症,是导致许多与肺相关死亡病例的原因。考虑到这些挑战,我们旨在总结分子和细胞机制,尤其关注导致急性和慢性肺损伤特征性病理生理学的气道炎症和氧化应激。此外,我们将强调当前治疗策略的局限性,并探索基于抗氧化剂的新药物选择,这些药物可能对治疗急性和慢性肺损伤有效。